Literature DB >> 8353081

Should we be using 5-HT3 antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?

J L Mansi, T R Evans, A Smith, C Oakley, R Wastnage, A Dalgleish.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8353081     DOI： 10.1093/oxfordjournals.annonc.a058531

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

Review 1.  Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.

Authors:  G L Plosker; P Benfield
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

2.  Cost-effectiveness analysis of antiemetic treatment.

Authors:  H Bleiberg; P Autier; D Michaux
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.